The 21Shares Injective Staking ETP, an innovative financial product, has crossed the $3 million milestone in assets under management. This achievement underscores the increasing investor confidence in the Injective Protocol, known for its decentralized finance capabilities, and emphasizes the importance of staking in investment portfolios.
Để lại một bình luận
Bạn phải đăng nhập để gửi bình luận.